Imogen Fitt[email protected]Clinical NewsIs the x-ray market set for a post-COVID bounceback?In the wake of COVID-19, the market for general radiography and fluoroscopy systems has experienced a significant shift, with chest x-ray examinations identified as a key tool to diagnose and track the progression of late-stage COVID-19. Imogen Fitt of Signify Research explains why a bounceback in equipment sales could be coming.June 24, 2020Clinical NewsPandemic causes major change in x-ray equipment marketChest x-ray examinations have become important for diagnosing and tracking the progression of late-stage COVID-19, and this promises to shake up the global market for radiography and fluoroscopy systems, writes analyst Imogen Fitt.June 21, 2020Page 1 of 1Top StoriesMolecular ImagingF-18 PSMA PET-CT proves clinical value in prostate cancerF-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.Molecular ImagingCombined PET scans predict progression of Alzheimer’sMolecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyMRIMRI-based nomogram provides boost in breast cancerCTCT estimated to cause 5% of new cancer cases